CB21 Pharma leads Europe in science-backed, trusted innovation for accessible CBD healthcare. Our portfolio includes the EU’s only three CE-marked cannabinoid medical devices, setting the standard for regulatory excellence and clinical validation.
Our science-backed solutions span Women’s Health, Proctology, Urology, Oral Care, and Mental Well-Being—delivering quality, efficacy, and safety to patients across 27 European markets.
We combine deep expertise in EU MDR compliance, GMP-certified manufacturing, and rapid adaptation to evolving pharmacopoeia standards.
Our integrated regulatory and IP strategy provides market exclusivity through 2041, offering partners a de-risked, scalable platform for transformative health solutions.
Company Details
- Employees
- 6
- Address
- Studentská 812, Brno,jihomoravský 625 00,czech Republic
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://cb21pharma.com/kontakt/
- Keywords
- Cannabinoid Medical Devices, CE Marking & EU MDR Compliance, Clinical Validation & Evidence-Based Development, Pan-European Market Access, GMP/API Manufacturing, Patent-Protected Innovation, Multi-Therapeutic Platform.
- HQ
- Brno, Jihomoravský
Cb21 Pharma Questions
Cb21 Pharma's website is https://cb21pharma.com/kontakt/
Cb21 Pharma's LinkedIn profile is https://cz.linkedin.com/company/cb21-pharma-s-r-o
Cb21 Pharma has
6 employees.
View email and phone details for 6
employees at Cb21 Pharma.
Cb21 Pharma's industry is
Pharmaceutical Manufacturing
Cb21 Pharma's top competitors are
Pharma Progress,
Arie Cb21,
Mihulka S.r.o.,
Cbdepot.eu,
Somaí,
Medi Pharma Vision, S.r.o.,
Gehe Pharma Praha, Spol. S R. O.,
Pharma Liftec Cz,
Dr. Kulich Pharma, S.r.o.,
Farmakem.
Cb21 Pharma's categories are Pharmaceutical Manufacturing
